These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 26580647)

  • 21. Age, sex, and race/ethnic temporal trends in metabolic syndrome prevalence among individuals with myocardial infarction or stroke in the United States.
    Lekoubou A; Ovbiagele B; Markovic D; Sanossian N; Towfighi A
    J Neurol Sci; 2017 May; 376():24-28. PubMed ID: 28431619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mediators of diabetic neuropathy: is hyperglycemia the only culprit?
    Grisold A; Callaghan BC; Feldman EL
    Curr Opin Endocrinol Diabetes Obes; 2017 Apr; 24(2):103-111. PubMed ID: 28098594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Components of metabolic syndrome and their combinations as predictors of cardiovascular disease in Japanese patients with type 2 diabetes. Implications for improved definition. Analysis from Japan Diabetes Complications Study (JDCS).
    Sone H; Tanaka S; Iimuro S; Oida K; Yamasaki Y; Oikawa S; Ishibashi S; Katayama S; Ito H; Ohashi Y; Akanuma Y; Yamada N
    J Atheroscler Thromb; 2009 Aug; 16(4):380-7. PubMed ID: 19672033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The metabolic syndrome and cognitive performance: the Northern Manhattan Study.
    Vieira JR; Elkind MS; Moon YP; Rundek T; Boden-Albala B; Paik MC; Sacco RL; Wright CB
    Neuroepidemiology; 2011; 37(3-4):153-9. PubMed ID: 22005335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical correlations and genetic associations of metabolic syndrome in the United Arab Emirates.
    Osman WM; Khan SM; Jelinek HF; Almahmeed W; Tay GK; Alsafar HS
    Gene; 2020 May; 738():144476. PubMed ID: 32061761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus.
    Ginsberg HN; MacCallum PR
    J Cardiometab Syndr; 2009; 4(2):113-9. PubMed ID: 19614799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship of peripheral arterial disease and metabolic syndrome prevalence in asymptomatic US adults 40 years and older: results from the National Health and Nutrition Examination Survey (1999-2004).
    Sumner AD; Khalil YK; Reed JF
    J Clin Hypertens (Greenwich); 2012 Mar; 14(3):144-8. PubMed ID: 22372773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic Syndrome Is Associated With Poor Cognition: A Population-Based Study of 70-Year-Old Adults Without Dementia.
    Marseglia A; Darin-Mattsson A; Skoog J; Rydén L; Hadarsson-Bodin T; Kern S; Rydberg Sterner T; Shang Y; Zettergren A; Westman E; Skoog I
    J Gerontol A Biol Sci Med Sci; 2021 Nov; 76(12):2275-2283. PubMed ID: 34228116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome.
    Kim B; Feldman EL
    Exp Mol Med; 2015 Mar; 47(3):e149. PubMed ID: 25766618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential impact of serum glucose, triglycerides, and high-density lipoprotein cholesterol on cardiovascular risk factor burden in nondiabetic, obese African American women: implications for the prevalence of metabolic syndrome.
    Gaillard T; Schuster D; Osei K
    Metabolism; 2010 Aug; 59(8):1115-23. PubMed ID: 20051282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis.
    Bora E; Akdede BB; Alptekin K
    Psychol Med; 2017 Apr; 47(6):1030-1040. PubMed ID: 28032535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic Syndrome and Its Effect on the Brain: Possible Mechanism.
    Arshad N'; Lin TS; Yahaya MF
    CNS Neurol Disord Drug Targets; 2018; 17(8):595-603. PubMed ID: 30047340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abdominal obesity, metabolic dysfunction, and metabolic syndrome in U.S. adolescents: National Health and Nutrition Examination Survey 2011-2016.
    Gaston SA; Tulve NS; Ferguson TF
    Ann Epidemiol; 2019 Feb; 30():30-36. PubMed ID: 30545765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of excluding hyperglycemia from international diabetes federation metabolic syndrome diagnostic criteria on prevalence of the syndrome and its association with microvascular complications, in adult patients with type 1 diabetes.
    Lecumberri E; Nattero-Chávez L; Quiñones Silva J; Alonso Díaz S; Fernández-Durán E; Dorado Avendaño B; Escobar-Morreale HF; Luque-Ramírez M
    Endocrine; 2022 Jun; 76(3):601-611. PubMed ID: 35349030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic syndrome and cognitive function in healthy middle-aged and older adults without diabetes.
    Gatto NM; Henderson VW; St John JA; McCleary C; Hodis HN; Mack WJ
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2008 Sep; 15(5):627-41. PubMed ID: 18608045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic syndrome and cognitive decline in early Alzheimer's disease and healthy older adults.
    Watts AS; Loskutova N; Burns JM; Johnson DK
    J Alzheimers Dis; 2013; 35(2):253-65. PubMed ID: 23388170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between metabolic syndrome and its components and cardiovascular disease in middle-aged and elderly Chinese population: a national cross-sectional survey.
    Li W; Song F; Wang X; Wang D; Chen D; Yue W; Zhang H; Wang Z; Lu Z
    BMJ Open; 2019 Aug; 9(8):e027545. PubMed ID: 31427317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus.
    Katsiki N; Anagnostis P; Kotsa K; Goulis DG; Mikhailidis DP
    Curr Pharm Des; 2019; 25(18):2051-2059. PubMed ID: 31298151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications.
    Penninx BWJH; Lange SMM
    Dialogues Clin Neurosci; 2018 Mar; 20(1):63-73. PubMed ID: 29946213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late-life metabolic syndrome prevents cognitive decline among older men aged 75 years and over: one-year prospective cohort study.
    Liu CL; Lin MH; Peng LN; Chen LK; Su CT; Liu LK; Chen LY
    J Nutr Health Aging; 2013; 17(6):523-6. PubMed ID: 23732548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.